Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Biodegradable scaffolds promote tissue remodeling and functional improvement in non-human primates with acute spinal cord injury.

Slotkin JR, Pritchard CD, Luque B, Ye J, Layer RT, Lawrence MS, O'Shea TM, Roy RR, Zhong H, Vollenweider I, Edgerton VR, Courtine G, Woodard EJ, Langer R.

Biomaterials. 2017 Apr;123:63-76. doi: 10.1016/j.biomaterials.2017.01.024. Epub 2017 Jan 25.

PMID:
28167393
2.

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.

Bourdenx M, Dovero S, Engeln M, Bido S, Bastide MF, Dutheil N, Vollenweider I, Baud L, Piron C, Grouthier V, Boraud T, Porras G, Li Q, Baekelandt V, Scheller D, Michel A, Fernagut PO, Georges F, Courtine G, Bezard E, Dehay B.

Acta Neuropathol Commun. 2015 Jul 25;3:46. doi: 10.1186/s40478-015-0222-2.

3.

Muscle spindle feedback directs locomotor recovery and circuit reorganization after spinal cord injury.

Takeoka A, Vollenweider I, Courtine G, Arber S.

Cell. 2014 Dec 18;159(7):1626-39. doi: 10.1016/j.cell.2014.11.019.

4.

Restoring voluntary control of locomotion after paralyzing spinal cord injury.

van den Brand R, Heutschi J, Barraud Q, DiGiovanna J, Bartholdi K, Huerlimann M, Friedli L, Vollenweider I, Moraud EM, Duis S, Dominici N, Micera S, Musienko P, Courtine G.

Science. 2012 Jun 1;336(6085):1182-5. doi: 10.1126/science.1217416.

5.

Antidepressant-like properties of α2-containing GABA(A) receptors.

Vollenweider I, Smith KS, Keist R, Rudolph U.

Behav Brain Res. 2011 Feb 2;217(1):77-80. doi: 10.1016/j.bbr.2010.10.009. Epub 2010 Oct 20.

6.

Proliferation of IL-2 activated lymphocytes preferably occurs in aggregates by cells expressing the CD57 antigen.

Vollenweider I, Lazzarato M, Groscurth P.

Scand J Immunol. 1995 Sep;42(3):381-6.

PMID:
7544913
7.

Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.

Vollenweider I, Moser R, Groscurth P.

Cancer Immunol Immunother. 1994 Nov;39(5):305-12.

PMID:
7987862
8.

Heterogeneous binding and killing behaviour of human gamma/delta-TCR+ lymphokine-activated killer cells against K562 and Daudi cells.

Vollenweider I, Vrbka E, Fierz W, Groscurth P.

Cancer Immunol Immunother. 1993 May;36(5):331-6.

PMID:
8477418
9.

Comparison of four DNA staining fluorescence dyes for measuring cell proliferation of lymphokine-activated killer (LAK) cells.

Vollenweider I, Groscurth P.

J Immunol Methods. 1992 Apr 27;149(1):133-5. No abstract available.

PMID:
1374777
10.

Ultrastructure of cell mediated cytotoxicity.

Vollenweider I, Groscurth P.

Electron Microsc Rev. 1991;4(2):249-67. Review.

PMID:
1932583
11.

Malignant haemangioendothelioma of the thyroid, immunohistochemical evidence of heterogeneity.

Vollenweider I, Hedinger C, Saremaslani P, Pfaltz M.

Pathol Res Pract. 1989 Apr;184(4):376-81.

PMID:
2471179
12.

Solid cell nests (SCN) in Hashimoto's thyroiditis.

Vollenweider I, Hedinger C.

Virchows Arch A Pathol Anat Histopathol. 1988;412(4):357-63.

PMID:
3125674
13.

Effects of washing and gel filtration on the ultrastructure of human platelets.

Groscurth P, Cheng S, Vollenweider I, von Felten A.

Acta Haematol. 1987;77(3):150-5.

PMID:
3113155
14.

Morphologic alterations of blood cells in the impedance aggregometer.

Lehmann K, Groscurth P, Vollenweider I, von Felten A, Rhyner K.

Blood Cells. 1985;11(2):325-36, 337-9.

PMID:
3834970

Supplemental Content

Loading ...
Support Center